Kadans Science Partner
-
Manchester’s Upper Brook Street site changes hands as part of £436m regen
Kadans to deliver 215,000 sq ft of lab and office space
-
Kadans opens up first phase of Tileyard Quarter in King’s Cross
Savills and DTRE appointed to fill up the space
-
Kadans hires director to put UK portfolio ‘on the map’
Bevan McWilliam joins as director of business for life sciences
-
Kadans seeks director to put UK portfolio ‘on the map’
Developer is recruiting for a newly created role focused on leasing
-
Gene therapy firm expands in Canary Wharf life sciences cluster
AviadoBio has consolidated space, bringing its 60-strong team under one roof
-
Kadans eyes F&B offering with Abingdon Science Park café
The developer has lodged plans for a 2,000 sq ft eatery for park tenants
-
Kadans gets go-ahead to deliver Cambridge lab
The 139,000 sq ft facility will be built, despite overdevelopment concerns
-
Major Manchester development gets go ahead
Upper Brook Street developers will deliver more than 1.2m sq ft of new commercial space
-
Kadans’ Cambridge lab scheme set for approval
Scheme recommended for approval at next council meeting
-
Manchester’s £436m Upper Brook Street scheme set for approval
Planners expected to provide a decision on Thursday this week
-
Kadans receives green light for King’s Cross R&D facility
Flexibilty has been a core driver of the design of the 55,000 sq ft building from inception
-
Cambridge defers decisions on high-rise labs
Developers await consent for Merlin Place and Vitrum schemes